Neuerungen im Management von Candida-Infektionen

The increasing incidence of <i>Candida</i> infections fueled by novel host factors and the rising prevalence of drug-resistant <i>Candida</i> isolates are growing global concerns. Outbreaks of <i>C. auris</i> and fluconazole-resistant <i>C. parapsilosis</i> are reported globally, posing a major threat to immunocompromised and critically ill patients. The rising resistance to azoles and echinocandins among <i>C. glabrata</i> presents additional challenges. In May 2025, the European Confederation